Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
62,036,250
-
Total 13F shares
-
66,716,414
-
Share change
-
+1,409,413
-
Total reported value
-
$6,891,080,476
-
Put/Call ratio
-
8.9%
-
Price per share
-
$103.26
-
Number of holders
-
177
-
Value change
-
+$149,538,106
-
Number of buys
-
95
-
Number of sells
-
69
Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q3 2022
As of 30 Sep 2022,
Ascendis Pharma A/S - American Depositary Shares (ASND) was held by
177 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,716,414 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, WESTFIELD CAPITAL MANAGEMENT CO LP, GOLDMAN SACHS GROUP INC, and Avoro Capital Advisors LLC.
This page lists
177
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.